The role of wide local excision of a primary lesion in cutaneous malignant melanoma: a retrospective analysis of its usefulness in local and general control of disease
- PMID: 39321036
- PMCID: PMC11524624
- DOI: 10.1097/CMR.0000000000000999
The role of wide local excision of a primary lesion in cutaneous malignant melanoma: a retrospective analysis of its usefulness in local and general control of disease
Abstract
Currently, wide local excision is recommended after the primary excision of cutaneous melanomas. The definition of margins for wide local excision indicated by the guidelines has remained unchanged over the years, although the reported indications are derived from fairly dated studies in which melanomas tended to be thicker or in advanced stages at diagnosis. This study aimed to retrospectively evaluate the usefulness of wide local excision for local and general control of the disease and to identify patients who had benefited from the wide local excision procedure in terms of prognosis improvement. This retrospective observational study was conducted on patients who had undergone surgery for melanoma at a single institution. The primary endpoint was progression-free survival after wide local excision in patients with or without residual melanoma. The secondary endpoint was to evaluate which patients' demographic features and melanoma histological data were associated with residual melanoma after wide local excision. In the univariate model, melanoma-positive wide local excision resulted in the worst progression-free survival; however, this association was not confirmed in the multivariate model. The results also showed that Breslow thickness was the only factor associated with an increased risk of metastasis to the wide local excision area. According to the receiver operating characteristic analysis, the optimum cutoff value of Breslow's thickness to predict a tumor-positive wide local excision was 2.31 mm for males and 2.4 mm for females.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.Ophthalmic Plast Reconstr Surg. 2003 Mar;19(2):96-101. doi: 10.1097/01.IOP.0000056141.97930.E8. Ophthalmic Plast Reconstr Surg. 2003. PMID: 12644753
-
A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.Br J Dermatol. 2004 Mar;150(3):523-30. doi: 10.1111/j.1365-2133.2004.05849.x. Br J Dermatol. 2004. PMID: 15030337
-
Frequency of and risk factors for tumor upstaging after wide local excision of primary cutaneous melanoma.J Am Acad Dermatol. 2017 Aug;77(2):341-348. doi: 10.1016/j.jaad.2017.03.018. J Am Acad Dermatol. 2017. PMID: 28601390
-
Recommended width of excision for primary malignant melanoma.World J Surg. 1995 May-Jun;19(3):343-5. doi: 10.1007/BF00299154. World J Surg. 1995. PMID: 7638984 Review.
-
"Personalized Excision" of Malignant Melanoma-Need for a Paradigm Shift in the Beginning Era of Personalized Medicine.Am J Dermatopathol. 2019 Dec;41(12):884-896. doi: 10.1097/DAD.0000000000001450. Am J Dermatopathol. 2019. PMID: 31490196 Review.
References
-
- Bolick NL, Geller AC. Epidemiology of melanoma. Hematol Oncol Clin North Am. 2021; 35:57–72. - PubMed
-
- Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. . European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022. Eur J Cancer. 2022; 170:256–284. - PubMed
-
- Swetter SM, Thompson JA, Albertini MR, Barker CA, Baumgartner J, Boland G, et al. . NCCN Guidelines® Insights: Melanoma: Cutaneous, version 2.2021. J Natl Compr Canc Netw. 2021; 19:364–376. - PubMed
-
- Zijlker LP, Eggermont AMM, van Akkooi ACJ. The end of wide local excision (WLE) margins for melanoma. Eur J Cancer. 2023; 178:82–87. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical